🔴 Sionna Therapeutics is trading 10.3% down today; no clear company-specific catalyst identified

Sionna Therapeutics is trading 10.3% down at $6.44, with no clear company-specific catalyst identified for September 18, 2026.

• Recent pressure likely reflects investor concern over the September 14 restructuring, including a 46% workforce reduction.
• The restructuring discontinued SION-719 as an add-on therapy and shifted focus toward SION-451 plus SION-2222.
• Those announcements predate today’s move, while biotechnology shares are broadly higher.